Financial Instruments - Additional Information (Detail) - USD ($) |
1 Months Ended | 12 Months Ended | ||||||
---|---|---|---|---|---|---|---|---|
Feb. 08, 2023 |
Sep. 30, 2023 |
Dec. 31, 2023 |
Jun. 30, 2025 |
Dec. 31, 2024 |
Jul. 31, 2023 |
Jul. 21, 2023 |
Feb. 03, 2023 |
|
Marketable Securities [Line Items] | ||||||||
Unrealized loss of securities | $ 0 | |||||||
Number of warrants to purchase common stock | 600,000 | |||||||
Common warrants liabilities | $ 1,222,000 | $ 1,548,000 | ||||||
Common warrants exercised | 1,400,000 | |||||||
Issuance of common stock upon warrant exercises | 924,000 | |||||||
Warrants exercise price | $ 0.66 | |||||||
Exercise price per share | $ 5 | $ 0.51 | ||||||
Monte-Carlo [Member] | ||||||||
Marketable Securities [Line Items] | ||||||||
Common warrants liabilities | $ 10,300,000 | $ 396,000 | 414,000 | |||||
Black-Scholes [Member] | ||||||||
Marketable Securities [Line Items] | ||||||||
Re-valued common warrants | $ 826,000 | $ 1,100,000 | $ 5,800,000 | |||||
Warrant [Member] | ||||||||
Marketable Securities [Line Items] | ||||||||
Number of warrants to purchase common stock | 2,000,000 | |||||||
Common Warrants [Member] | ||||||||
Marketable Securities [Line Items] | ||||||||
Number of warrants to purchase common stock | 2,991,027 |